|
USRE34656E
(en)
*
|
1983-12-29 |
1994-07-05 |
The Research Foundation Of State University Of New York |
Use of tetracycline to enhance bone protein synthesis and/or treatment of bone deficiency
|
|
ES8802468A1
(es)
*
|
1985-05-02 |
1988-07-16 |
Research Corp |
Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
|
|
US5308839A
(en)
*
|
1989-12-04 |
1994-05-03 |
The Research Foundation Of State University Of New York |
Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
|
|
JP3016587B2
(ja)
*
|
1989-12-04 |
2000-03-06 |
ザ・リサーチ・ファンデーション・オブ・ステート・ユニバーシティ・オブ・ニューヨーク |
非ステロイド抗炎症剤及びテトラサイクリンの配合
|
|
US5045538A
(en)
*
|
1990-06-28 |
1991-09-03 |
The Research Foundation Of State University Of New York |
Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines
|
|
AU1411992A
(en)
*
|
1991-01-15 |
1992-08-27 |
Robert A Bok |
A composition containing a tetracycline and use for inhibiting angiogenesis
|
|
US5770588A
(en)
*
|
1991-02-11 |
1998-06-23 |
The Research Foundation Of State University Of New York |
Non-antibacterial tetracycline compositions of the prevention and treatment of root caries
|
|
US5223248A
(en)
*
|
1991-02-11 |
1993-06-29 |
The Research Foundation Of State University Of New York |
Non-antibacterial tetracycline compositions possessing antiplaque properties
|
|
CA2094874C
(en)
*
|
1992-04-27 |
2003-02-11 |
Thomas F. Mcnamara |
Non-antibacterial tetracycline compositons possessing antiplaque properties
|
|
US5258371A
(en)
*
|
1992-05-29 |
1993-11-02 |
Kuraray Co., Ltd. |
Method to reduce connective tissue destruction
|
|
US5700485A
(en)
*
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
|
US5922340A
(en)
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
|
DE69331387T2
(de)
*
|
1992-09-10 |
2002-08-22 |
Childrens Medical Center |
Biodegradierbare polymeren matrizen mit verzoegerter freisetzung von lokalanaesthetika
|
|
US6043231A
(en)
*
|
1993-03-02 |
2000-03-28 |
The Research Foundation Of State Univ. Of New York |
Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
|
|
US5523297A
(en)
*
|
1993-03-02 |
1996-06-04 |
The Research Foundation Of State University Of New York |
Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
|
|
US6140099A
(en)
*
|
1994-05-20 |
2000-10-31 |
The Trustees Of The University Of Pennsylvania |
Method of delaying fetal membrane rupture by inhibiting matrix metalloproteinase-9 activity
|
|
US5641636A
(en)
*
|
1994-05-20 |
1997-06-24 |
University Of Pennsylvania |
Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity
|
|
US5942241A
(en)
|
1995-06-09 |
1999-08-24 |
Euro-Celtique, S.A. |
Formulations and methods for providing prolonged local anesthesia
|
|
AU733867B2
(en)
|
1996-06-24 |
2001-05-31 |
Euro-Celtique S.A. |
Methods for providing safe local anesthesia
|
|
US5827840A
(en)
*
|
1996-08-01 |
1998-10-27 |
The Research Foundation Of State University Of New York |
Promotion of wound healing by chemically-modified tetracyclines
|
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
|
US5773430A
(en)
*
|
1997-03-13 |
1998-06-30 |
Research Foundation Of State University Of New York |
Serine proteinase inhibitory activity by hydrophobic tetracycline
|
|
JP2908375B2
(ja)
|
1997-04-01 |
1999-06-21 |
ザ リサーチ ファンデーション オブ ステート ユニバーシティ オブ ニューヨーク |
非抗バクテリア性テトラサイクリン組成物
|
|
IL129951A0
(en)
|
1997-07-02 |
2000-02-29 |
Euro Celtique Sa |
Prolonged anesthesia in joints and body spaces
|
|
AU8918898A
(en)
|
1997-08-25 |
1999-03-16 |
Harold Brem |
Prevention of adhesions and excessive scar formation using angiogenesis inhibi tors
|
|
DK1041991T3
(da)
*
|
1997-12-19 |
2008-07-28 |
Univ New York |
Ikke-antibakterielle tetracycliner til behandling af multipel sklerose
|
|
ES2338946T3
(es)
*
|
1998-02-13 |
2010-05-13 |
Nutramax Laboratories, Inc. |
Agentes y procedimientos para la proteccion, tratamiento y reparacion del tejido conjuntivo.
|
|
US6277061B1
(en)
*
|
1998-03-31 |
2001-08-21 |
The Research Foundation Of State University Of New York |
Method of inhibiting membrane-type matrix metalloproteinase
|
|
CA2332369A1
(en)
*
|
1998-05-27 |
1999-12-02 |
Euroceltique S.A. |
Drug delivery system comprising a tightly compacted solid medicament stock
|
|
US6015804A
(en)
*
|
1998-09-11 |
2000-01-18 |
The Research Foundation Of State University Of New York |
Method of using tetracycline compounds to enhance interleukin-10 production
|
|
US5998390A
(en)
*
|
1998-09-28 |
1999-12-07 |
The Research Foundation Of State University Of New York |
Combination of bisphosphonate and tetracycline
|
|
US6946453B2
(en)
|
1998-11-18 |
2005-09-20 |
Collagenex Pharmaceuticals, Inc. |
4-dedimethylaminotracycline derivatives
|
|
US6506740B1
(en)
|
1998-11-18 |
2003-01-14 |
Robert A. Ashley |
4-dedimethylaminotetracycline derivatives
|
|
US7300667B1
(en)
|
1999-05-27 |
2007-11-27 |
Euro-Celtique, S.A. |
Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
|
|
US6294694B1
(en)
|
1999-06-04 |
2001-09-25 |
Wisconsin Alumni Research Foundation |
Matrix metalloproteinase inhibitors and method of using same
|
|
US6673843B2
(en)
*
|
1999-06-30 |
2004-01-06 |
Emory University |
Curcumin and curcuminoid inhibition of angiogenesis
|
|
US20020132798A1
(en)
|
2000-06-16 |
2002-09-19 |
Nelson Mark L. |
7-phenyl-substituted tetracycline compounds
|
|
US7211267B2
(en)
|
2001-04-05 |
2007-05-01 |
Collagenex Pharmaceuticals, Inc. |
Methods of treating acne
|
|
CA2447008A1
(en)
*
|
2001-04-05 |
2002-10-24 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
EP1408987B1
(en)
|
2001-07-13 |
2013-04-10 |
Paratek Pharmaceuticals, Inc. |
Tetracycline compounds having target therapeutic activities
|
|
US20060194773A1
(en)
*
|
2001-07-13 |
2006-08-31 |
Paratek Pharmaceuticals, Inc. |
Tetracyline compounds having target therapeutic activities
|
|
WO2003030819A2
(en)
*
|
2001-10-05 |
2003-04-17 |
Tetragenex Pharmaceuticals, Inc. |
Tetracycline derivatives and methods of use thereof
|
|
EP2311797A1
(en)
|
2002-01-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
4-dedimethylamino tetracycline compounds
|
|
US20090011991A1
(en)
*
|
2002-03-08 |
2009-01-08 |
Emory University |
Novel Curcuminoid-Factor VIIA Constructs as Suppressors of Tumor Growth and Angiogenesis
|
|
JP2005529080A
(ja)
*
|
2002-03-08 |
2005-09-29 |
エモリー ユニバーシティ |
腫瘍の増殖および脈管形成のサプレッサとしての新規のクルクミノイド−第VIIa因子構築物
|
|
JP2005526754A
(ja)
|
2002-03-08 |
2005-09-08 |
パラテック ファーマシューティカルズ インコーポレイテッド |
アミノメチル置換されたテトラサイクリン化合物
|
|
EP1503981A4
(en)
|
2002-03-21 |
2007-08-15 |
Paratek Pharm Innc |
SUBSTITUTED TETRACYCLINE COMPOUNDS
|
|
WO2003082011A1
(en)
*
|
2002-03-29 |
2003-10-09 |
The Research Foundation Of State University Of New York |
Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
|
|
WO2004006850A2
(en)
|
2002-07-12 |
2004-01-22 |
Paratek Pharmaceuticals, Inc |
3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
|
|
AU2003296482A1
(en)
*
|
2002-12-13 |
2004-07-09 |
The Research Foundation Of State University Of New York |
Tetracyclines as anti-fungal agents for treatment of ringworm
|
|
CA2521885C
(en)
*
|
2003-04-07 |
2013-06-25 |
Shire Laboratories, Inc. |
Once daily formulations of tetracyclines
|
|
WO2005009943A2
(en)
|
2003-07-09 |
2005-02-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
JP4738333B2
(ja)
|
2003-07-09 |
2011-08-03 |
パラテック ファーマシューティカルズ インコーポレイテッド |
9−アミノメチルテトラサイクリン化合物のプロドラッグ
|
|
EP1684768A4
(en)
*
|
2003-11-06 |
2007-06-06 |
Univ New York State Res Found |
METHOD FOR TREATING ECCEM
|
|
EP2332904A3
(en)
*
|
2004-01-15 |
2012-04-11 |
Paratek Pharmaceuticals, Inc. |
Derivatives of tetracycline compounds
|
|
JP2008518025A
(ja)
|
2004-10-25 |
2008-05-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
4−アミノテトラサイクリンおよびその使用の方法
|
|
WO2006047756A2
(en)
|
2004-10-25 |
2006-05-04 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
BRPI0602372B8
(pt)
|
2006-05-18 |
2021-06-22 |
Einco Biomaterial Ltda |
processo de preparação de compósitos em base de biocerâmicas e polímeros biodegradáveis e produto derivado
|
|
PL2120963T3
(pl)
|
2006-12-21 |
2019-05-31 |
Paratek Pharm Innc |
Podstawione związki tetracyklinowe do leczenia zaburzeń zapalnych skóry
|
|
IL270446B2
(en)
*
|
2006-12-21 |
2023-10-01 |
Paratek Pharm Innc |
A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition
|
|
EP2144870A2
(en)
*
|
2007-04-27 |
2010-01-20 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing and purifying aminoalkyl tetracycline compounds
|
|
WO2009009042A1
(en)
*
|
2007-07-06 |
2009-01-15 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing substituted tetracycline compounds
|
|
TWI585071B
(zh)
|
2008-05-19 |
2017-06-01 |
派洛泰克藥物股份有限公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
|
HUE026562T2
(hu)
|
2008-08-08 |
2016-06-28 |
Tetraphase Pharmaceuticals Inc |
C7-fluor-helyettesített tetraciklin vegyületek
|
|
CN102459153A
(zh)
|
2009-05-08 |
2012-05-16 |
四相制药公司 |
四环素类化合物
|
|
EP2470500B1
(en)
|
2009-08-28 |
2017-10-04 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
|
WO2011123536A1
(en)
|
2010-03-31 |
2011-10-06 |
Tetraphase Pharmaceuticals, Inc. |
Polycyclic tetracycline compounds
|
|
CN104394856A
(zh)
*
|
2012-05-21 |
2015-03-04 |
Dcb美国公司 |
以斑马鱼模型进行药物筛选的方法及筛选所得药物
|
|
TR201902057T4
(tr)
|
2012-08-31 |
2019-03-21 |
Tetraphase Pharmaceuticals Inc |
Tetrasiklin bileşikleri.
|
|
MA46567A
(fr)
|
2016-10-19 |
2019-08-28 |
Tetraphase Pharmaceuticals Inc |
Formes cristallines de l'éravacycline
|
|
WO2020097450A1
(en)
|
2018-11-09 |
2020-05-14 |
Tetraphase Pharmaceuticals, Inc. |
Polymorphic forms of a compound and uses thereof
|